These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20598155)

  • 21. Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours.
    Merron A; Baril P; Martin-Duque P; de la Vieja A; Tran L; Briat A; Harrington KJ; McNeish IA; Vassaux G
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1377-85. PubMed ID: 20140612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the
    Iannuzzi CA; Indovina P; Forte IM; Di Somma S; Malfitano AM; Bruno M; Portella G; Pentimalli F; Giordano A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33020398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.
    Höti N; Chowdhury WH; Mustafa S; Ribas J; Castanares M; Johnson T; Liu M; Lupold SE; Rodriguez R
    Cancer Gene Ther; 2010 Aug; 17(8):585-97. PubMed ID: 20448671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective effects of E1B-defective adenoviruses and adenovirus E1A mutants in deficient mouse primary embryonic fibroblasts.
    Martin Duque P; Parada C; Guinea J; Sanchez-Prieto R; Ramon Y Cajal S
    Int J Oncol; 2001 Jun; 18(6):1163-7. PubMed ID: 11351246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
    Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
    Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.
    Satoh M; Wang H; Ishidoya S; Abe H; Moriya T; Hamada H; Arai Y
    Urology; 2007 Dec; 70(6):1243-8. PubMed ID: 18158069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
    O'Shea CC; Johnson L; Bagus B; Choi S; Nicholas C; Shen A; Boyle L; Pandey K; Soria C; Kunich J; Shen Y; Habets G; Ginzinger D; McCormick F
    Cancer Cell; 2004 Dec; 6(6):611-23. PubMed ID: 15607965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo.
    Botta G; Passaro C; Libertini S; Abagnale A; Barbato S; Maione AS; Hallden G; Beguinot F; Formisano P; Portella G
    Hum Gene Ther; 2012 Jun; 23(6):623-34. PubMed ID: 22475378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus.
    Rein DT; Volkmer A; Beyer IM; Curiel DT; Janni W; Dragoi A; Hess AP; Maass N; Baldus SE; Bauerschmitz G; Breidenbach M
    Gynecol Oncol; 2011 Oct; 123(1):138-46. PubMed ID: 21741695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [E1A oncogene effect on the ability of p21(Waf1) to regulate G1/S arrest in E1A-expressing transformants following irradiation].
    Romanov VS; Brichkina AI; Pospelov VA; Pospelova TV
    Tsitologiia; 2005; 47(12):1063-70. PubMed ID: 16706194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
    Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
    Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status.
    Heise C; Ganly I; Kim YT; Sampson-Johannes A; Brown R; Kirn D
    Gene Ther; 2000 Nov; 7(22):1925-9. PubMed ID: 11127580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by down-regulating Neu expression and preserving Rb function.
    Fang L; Huang Y; Hu X; Sun L; He X; Hu H; Pu Y; Cao X; Luo H; Pan S; Gu J; Su C
    Chem Biol Interact; 2009 Sep; 181(1):1-7. PubMed ID: 19523934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.
    Vasey PA; Shulman LN; Campos S; Davis J; Gore M; Johnston S; Kirn DH; O'Neill V; Siddiqui N; Seiden MV; Kaye SB
    J Clin Oncol; 2002 Mar; 20(6):1562-9. PubMed ID: 11896105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer.
    Kimball KJ; Rivera AA; Zinn KR; Icyuz M; Saini V; Li J; Zhu ZB; Siegal GP; Douglas JT; Curiel DT; Alvarez RD; Borovjagin AV
    Mol Imaging; 2009; 8(5):264-77. PubMed ID: 19796604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing Activity.
    Sakurai F; Nishimae F; Takayama K; Mizuguchi H
    Anticancer Res; 2021 Feb; 41(2):773-782. PubMed ID: 33517282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.